BIO-key International (NASDAQ:BKYI – Get Free Report) was upgraded by analysts at Wall Street Zen to a “sell” rating in a research note issued to investors on Saturday.
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of BIO-key International in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.
Get Our Latest Analysis on BKYI
BIO-key International Stock Up 9.4%
BIO-key International (NASDAQ:BKYI – Get Free Report) last released its quarterly earnings results on Friday, November 14th. The technology company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.03). BIO-key International had a negative net margin of 70.23% and a negative return on equity of 73.33%. The firm had revenue of $1.55 million during the quarter, compared to the consensus estimate of $1.80 million.
About BIO-key International
BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.
In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.
Read More
- Five stocks we like better than BIO-key International
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- 3 Overlooked Deductions to Help Potentially Minimize Capital Gains Tax
- First Time Since 2007: All Warnings Active
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
